Mira Pharmaceuticals, Common Stock Price Prediction
| MIRA Stock | 1.29 0.02 1.57% |
Oversold Vs Overbought
48
Oversold | Overbought |
EPS Estimate Next Quarter (0.17) | EPS Estimate Current Year (0.56) | EPS Estimate Next Year (0.57) | Wall Street Target Price 12.0833 | EPS Estimate Current Quarter (0.15) |
Using MIRA Pharmaceuticals, hype-based prediction, you can estimate the value of MIRA Pharmaceuticals, Common from the perspective of MIRA Pharmaceuticals, response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MIRA Pharmaceuticals, to buy its stock at a price that has no basis in reality. In that case, they are not buying MIRA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MIRA Pharmaceuticals, after-hype prediction price | USD 1.33 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
MIRA |
MIRA Pharmaceuticals, After-Hype Price Prediction Density Analysis
As far as predicting the price of MIRA Pharmaceuticals, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MIRA Pharmaceuticals, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MIRA Pharmaceuticals,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MIRA Pharmaceuticals, Estimiated After-Hype Price Volatility
In the context of predicting MIRA Pharmaceuticals,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MIRA Pharmaceuticals,'s historical news coverage. MIRA Pharmaceuticals,'s after-hype downside and upside margins for the prediction period are 0.07 and 8.47, respectively. We have considered MIRA Pharmaceuticals,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MIRA Pharmaceuticals, is risky at this time. Analysis and calculation of next after-hype price of MIRA Pharmaceuticals, is based on 3 months time horizon.
MIRA Pharmaceuticals, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MIRA Pharmaceuticals, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MIRA Pharmaceuticals, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MIRA Pharmaceuticals,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 7.14 | 0.04 | 0.06 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.29 | 1.33 | 3.10 |
|
MIRA Pharmaceuticals, Hype Timeline
MIRA Pharmaceuticals, is now traded for 1.29. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.06. MIRA is projected to increase in value after the next headline, with the price projected to jump to 1.33 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 3.1%, whereas the daily expected return is now at -0.29%. The volatility of related hype on MIRA Pharmaceuticals, is about 3187.5%, with the expected price after the next announcement by competition of 1.35. MIRA Pharmaceuticals, Common currently holds 5.06 K in liabilities. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out MIRA Pharmaceuticals, Basic Forecasting Models to cross-verify your projections.MIRA Pharmaceuticals, Related Hype Analysis
Having access to credible news sources related to MIRA Pharmaceuticals,'s direct competition is more important than ever and may enhance your ability to predict MIRA Pharmaceuticals,'s future price movements. Getting to know how MIRA Pharmaceuticals,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MIRA Pharmaceuticals, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRNX | Crinetics Pharmaceuticals | (1.21) | 11 per month | 2.47 | (0.01) | 3.67 | (3.45) | 16.75 | |
| ENTA | Enanta Pharmaceuticals | (0.41) | 8 per month | 0.00 | (0.28) | 3.68 | (4.76) | 11.52 | |
| FOLD | Amicus Therapeutics | (0.26) | 10 per month | 0.00 | (0.11) | 3.16 | (3.58) | 18.26 | |
| CNTB | Connect Biopharma Holdings | 0.01 | 5 per month | 5.44 | 0.03 | 12.12 | (9.01) | 48.67 | |
| LGND | Ligand Pharmaceuticals Incorporated | 2.81 | 10 per month | 2.44 | 0.04 | 4.11 | (4.58) | 17.78 | |
| PASG | Passage Bio | 0.03 | 8 per month | 5.91 | 0.1 | 12.07 | (10.45) | 32.24 | |
| ORIC | Oric Pharmaceuticals | 0.03 | 8 per month | 4.34 | (0.03) | 5.64 | (5.18) | 23.18 | |
| LYEL | Lyell Immunopharma | 0.11 | 7 per month | 0.00 | (0.08) | 13.39 | (9.47) | 36.92 | |
| DSGN | Design Therapeutics | (0.24) | 5 per month | 5.08 | 0.07 | 9.43 | (7.45) | 35.31 | |
| RVMD | Revolution Medicines | 1.37 | 9 per month | 2.00 | 0.14 | 4.81 | (3.24) | 10.95 |
MIRA Pharmaceuticals, Additional Predictive Modules
Most predictive techniques to examine MIRA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MIRA using various technical indicators. When you analyze MIRA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MIRA Pharmaceuticals, Predictive Indicators
The successful prediction of MIRA Pharmaceuticals, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MIRA Pharmaceuticals, Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MIRA Pharmaceuticals, based on analysis of MIRA Pharmaceuticals, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MIRA Pharmaceuticals,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MIRA Pharmaceuticals,'s related companies.
Story Coverage note for MIRA Pharmaceuticals,
The number of cover stories for MIRA Pharmaceuticals, depends on current market conditions and MIRA Pharmaceuticals,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MIRA Pharmaceuticals, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MIRA Pharmaceuticals,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MIRA Pharmaceuticals, Short Properties
MIRA Pharmaceuticals,'s future price predictability will typically decrease when MIRA Pharmaceuticals,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MIRA Pharmaceuticals, Common often depends not only on the future outlook of the potential MIRA Pharmaceuticals,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MIRA Pharmaceuticals,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.6 M | |
| Cash And Short Term Investments | 4.6 M |
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals,'s price analysis, check to measure MIRA Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals, is operating at the current time. Most of MIRA Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |